- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
D.Western Therapeutics Institute Inc+ Add to Watchlist
6DW:GR17.485 EUR 0.790 4.32%
As of 02:12:49 ET on 08/01/2014.
Company Profile for D.Western Therapeutics Institute Inc (6DW)
D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.
D.Western Therapeutics Institute Inc
Key Executives for D.Western Therapeutics Institute Inc (6DW)
|Hiroyoshi HidakaChairman/Chief Scientist Ofcr||Yuichi HidakaPresident/CEO|
|Ayako KamikuboDirector||Masakatsu NishikawaDirector|